Fingerprint
Dive into the research topics of 'A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease
William J Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranic, Wenjin Wang, Wojciech Niezychowski, Study A3921043 Investigators
Research output: Contribution to journal › Article › peer-review
197
Citations
(Scopus)